Literature DB >> 10499272

Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method.

A Armson1, B P Meloni, J A Reynoldson, R C Thompson.   

Abstract

A rapid semi-quantitative screening method was devised for assessing the anticryptosporidial and cytotoxic effects of putative chemotherapeutic compounds. The method is suitable as an initial rapid screening procedure from which compounds demonstrating anticryptosporidial activity can be identified for further analysis. It has the advantages of speed, low cost and concurrent assessment of anticryptosporidial and cytotoxic effects and allows accurate determination of minimum lethal concentrations. Of the 71 compounds screened, six completely inhibited cryptosporidial growth at 1 microM (monensin, salinomycin, alborixin, lasalocid, trifluralin and nicarbazin) and a further eight showed significant anticryptosporidial activity at 1 or 20 microM (halquinol, bleomycin, suramin, mitomycin, doxycycline hydrochloride, toltrazuril, chloroquine phosphate and teniposide). Twelve compounds were found to have some degree of cytotoxicity at 1 microM and a further 12 at 20 microM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499272     DOI: 10.1111/j.1574-6968.1999.tb08681.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  13 in total

1.  In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.

Authors:  Klaus Teichmann; Maxime Kuliberda; Gerd Schatzmayr; Franz Hadacek; Anja Joachim
Journal:  Parasitol Res       Date:  2012-01-26       Impact factor: 2.289

2.  Characterization of trifluralin binding with recombinant tubulin from Trypanosoma brucei.

Authors:  Natalie L Giles; Anthony Armson; Simon A Reid
Journal:  Parasitol Res       Date:  2008-12-03       Impact factor: 2.289

3.  Development and validation of a cell culture based assay for in vitro assessment of anticryptosporidial compounds.

Authors:  M Najdrowski; A R Heckeroth; C Wackwitz; S Gawlowska; U Mackenstedt; D Kliemt; A Daugschies
Journal:  Parasitol Res       Date:  2007-01-10       Impact factor: 2.289

4.  Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.

Authors:  Shahira A Ahmed; Heba S El-Mahallawy; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

Review 5.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

6.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

7.  Identification of a novel Cryptosporidium genotype in pigs.

Authors:  U M Ryan; B Samarasinghe; C Read; J R Buddle; I D Robertson; R C A Thompson
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

8.  Integrated mapping, chromosomal sequencing and sequence analysis of Cryptosporidium parvum.

Authors:  Alan T Bankier; Helen F Spriggs; Berthold Fartmann; Bernard A Konfortov; Martin Madera; Christine Vogel; Sarah A Teichmann; Al Ivens; Paul H Dear
Journal:  Genome Res       Date:  2003-07-17       Impact factor: 9.043

9.  Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.

Authors:  Autumn S Downey; Curtis R Chong; Thaddeus K Graczyk; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

10.  Intra-isolate variation of Cryptosporidium parvum small subunit ribosomal RNA genes from human hosts in England.

Authors:  Cindy Gibbons-Matthews; Annette M Prescott
Journal:  Parasitol Res       Date:  2003-05-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.